Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Characterization of novel human leukemia genes identified by in vivo retroviral mutagenesis screening
EF 2010-11
Résumé
By understanding the mechanisms involved in cancers, we are able to develop targeted therapies for their treatment. The elucidation of the molecular pathways that are disturbed and the genes that are mutated have aided in identifying: patients at risk, patients with altered prognosis and patients that will benefit from specific treatments. For these reasons, it is important to study the genetic changes that occur converting a healthy cell into a cancerous one.
One method of identifying the genes involved is through the induction of cancer via gene disturbances in animal models. Recent advances have allowed the establishment of humanized animal models, in which portions of the human blood system can be established within animals, and thus cancer caused by the disturbances of human genes can be studied. In one case, this was achieved by infecting human cells with a virus containing a known oncogene and transplanting the cells into mice. The mice developed a variety of leukemias and I found evidence that the genes disrupted by the insertion of the virus into the genome also contributed to the leukemic development. The screening of many leukemias in this manner identified a large list of genes including some with known cancer affiliations and some not previously reported. Thus the generation of viral insertions opens a way to identify genes that co-operate with the known oncogene present in the virus.
The goal of this work is to identify the potential roles of genes found in a large scale screen of viral insertions in the development and progression of leukemia. First, additional oncogene induced leukemias will be generated to identify a broader list of genes. A subset of these genes, including those that were identified on multiple occasions will then be studied to determine their roles in the leukemic process. This screening method will aid in the identification of genes with important implications in human leukemia as well as potential new therapeutic targets.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
225384
Name
Dobson Stephanie M
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Characterization of novel human leukemia genes identified by in vivo retroviral mutagenesis screening
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cancer Genetics; Gene Knockdown; Gene Overexpression; Humanized Genetic Mouse Model; Insertional Mutagenesis Screen; Leukaemia; Retroviral Transductions; Retroviruses; Splinkerette Pcr; Stem Cells/ Cancer Stem Cells
Abstract
By understanding the mechanisms involved in cancers, we are able to develop targeted therapies for their treatment. The elucidation of the molecular pathways that are disturbed and the genes that are mutated have aided in identifying: patients at risk, patients with altered prognosis and patients that will benefit from specific treatments. For these reasons, it is important to study the genetic changes that occur converting a healthy cell into a cancerous one.
One method of identifying the genes involved is through the induction of cancer via gene disturbances in animal models. Recent advances have allowed the establishment of humanized animal models, in which portions of the human blood system can be established within animals, and thus cancer caused by the disturbances of human genes can be studied. In one case, this was achieved by infecting human cells with a virus containing a known oncogene and transplanting the cells into mice. The mice developed a variety of leukemias and I found evidence that the genes disrupted by the insertion of the virus into the genome also contributed to the leukemic development. The screening of many leukemias in this manner identified a large list of genes including some with known cancer affiliations and some not previously reported. Thus the generation of viral insertions opens a way to identify genes that co-operate with the known oncogene present in the virus.
The goal of this work is to identify the potential roles of genes found in a large scale screen of viral insertions in the development and progression of leukemia. First, additional oncogene induced leukemias will be generated to identify a broader list of genes. A subset of these genes, including those that were identified on multiple occasions will then be studied to determine their roles in the leukemic process. This screening method will aid in the identification of genes with important implications in human leukemia as well as potential new therapeutic targets.
Competitiondate
201102
Approvedterm2
1 yr 0 mth
Pinamesdelim
Dobson, Stephanie M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~